Last reviewed · How we verify

NCT06679114: SHAWL

Preventing Mental Disorders Among Women Internally Displaced by War in Ukraine: The SHAWL Trial

Completed NA Last updated 16 January 2026
What this trial tests

NA trial testing Acceptance and Commitment Therapy in Anxiety in 120 participants. Completed in 10 January 2026.

Timeline
27 March 2025
Primary endpoint
10 January 2026
10 January 2026

Quick facts

Lead sponsorBoston Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment120
Start date27 March 2025
Primary completion10 January 2026
Estimated completion10 January 2026
Sites1 location across Ukraine

Drugs / interventions tested

Conditions studied

Sponsor

Boston Medical Center

Who can join

18 and older, female only, with Anxiety or Mental Health Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a randomized controlled trial among 120 recently displaced women to determine the effectiveness of a single-session Acceptance and Commitment Therapy (ACT) group therapy on prevention of development of mental health disorders or worsened mental health symptoms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Acceptance and Commitment Therapy

Trials testing the same drug.

Other recruiting trials for Anxiety

Currently open trials in the same condition.

Other Boston Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06679114.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing